Tetsuyuki Yasuda

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

<i>PAX6</i> Mutation as a Genetic Factor Common to Aniridia and Glucose Intolerance

Tetsuyuki Yasuda, Yoshitaka Kajimoto, Yoshio Fujitani et al. · Diabetes · 2002 · 143 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Probucol preserves pancreatic β-cell function through reduction of oxidative stress in type 2 diabetes

Shin-ichi Gorogawa, Yoshitaka Kajimoto, Yutaka Umayahara et al. · Diabetes Research and Clinical Practice · 2002 · 115 citations

Medicine, Cell Biology, Endocrinology +16

Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

Keiko K. Fujisawa, Naoto Katakami, Hideaki Kaneto et al. · Atherosclerosis · 2013 · 100 citations

Medicine, Cardiology, Endocrinology +16